Pasar al contenido principal

BIOMARCADORES DE AUTORRENOVACION Y TRANSICION EPITELIO-MESENQUIMA EN EL PRONOSTICO, LA PREDICCION Y EL DIAGNOSTICO PRECOZ DE LOS CARCINOMAS DE PROSTATA Y MAMA

SAF2012-40017-C02-02

•
Nombre agencia financiadora Ministerio de Economía y Competitividad
Acrónimo agencia financiadora MINECO
Programa Programa Nacional de Proyectos de Investigación Fundamental
Subprograma Subprograma de Proyectos de Investigación Fundamental no Orientada
Convocatoria Proyectos I+D
Año convocatoria 2012
Plan Estatal 2008-2011 Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica
Unidad de gestión Secretaría de Estado de Investigación, Desarrollo e Innovación
Centro beneficiario FUNDACIÓ DE RECERCA CLÍNIC BARCELONA-INSTITUT D'INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER
Identificador persistente http://dx.doi.org/10.13039/501100003329

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

MicroRNA-200, associated with metastatic breast cancer, promotes traits of mammary luminal progenitor cells

  • Sánchez-Cid, Lourdes
  • Pons, Mònica
  • Lozano, Juan José
  • Rubio, Nuria
  • Guerra-Rebollo, Marta
  • Soriano, Aroa|||0000-0001-9659-1471
  • Paris-Coderch, Laia
  • Segura, Miquel F.
  • Fueyo Arévalo, Raquel
  • Arguimbau, Judit
  • Zodda, Erika
  • Bermudo, Raquel
  • Alonso, Immaculada
  • Caparrós, Xavier
  • Cascante, Marta
  • Rafii, Arash
  • Kang, Yibin
  • Martínez-Balbás, Marian
  • Weiss, Stephen J.
  • Blanco Fernández, Jerónimo
  • Muñoz, Montserrat
  • Fernández, Pedro Luis|||0000-0002-8618-4597
  • Thomson, Timothy M.
MicroRNAs are critical regulators of gene networks in normal and abnormal biological processes. Focusing on invasive ductal breast cancer (IDC), we have found dysregulated expression in tumor samples of several microRNAs, including the miR-200 family, along progression from primary tumors to distant metastases, further reflected in higher blood levels of miR-200b and miR-7 in IDC patients with regional or distant metastases relative to patients with primary node-negative tumors. Forced expression of miR-200s in MCF10CA1h mammary cells induced an enhanced epithelial program, aldehyde dehydrogenase (ALDH) activity, mammosphere growth and ability to form branched tubuloalveolar structures while promoting orthotopic tumor growth and lung colonization in vivo. MiR-200s also induced the constitutive activation of the PI3K-Akt signaling through downregulation of PTEN, and the enhanced mammosphere growth and ALDH activity induced in MCF10CA1h cells by miR-200s required the activation of this signaling pathway. Interestingly, the morphology of tumors formed in vivo by cells expressing miR-200s was reminiscent of metaplastic breast cancer (MBC). Indeed, the epithelial components of MBC samples expressed significantly higher levels of miR-200s than their mesenchymal components and displayed a marker profile compatible with luminal progenitor cells. We propose that microRNAs of the miR-200 family promote traits of highly proliferative breast luminal progenitor cells, thereby exacerbating the growth and metastatic properties of transformed mammary epithelial cells.